Full Text View
Tabular View
No Study Results Posted
Related Studies
The Treatment Advocacy Program
This study is ongoing, but not recruiting participants.
Study NCT00164333   Information provided by Centers for Disease Control and Prevention
First Received: September 9, 2005   No Changes Posted

September 9, 2005
September 9, 2005
September 2004
 
Self-reported, unprotected (without condoms) anal or vaginal sex with HIV-negative or unknown-status partners.
Same as current
No Changes Posted
Self-reported incidences of missed doses of treatment regimen.
Same as current
 
The Treatment Advocacy Program
The Treatment Advocacy Program

The purpose of the study is to test the efficacy of TAP, a behavioral intervention, in improving sexual safety and treatment adherence among gay and bisexual men infected with HIV. It is hypothesized that those who are in the intervention group will report reductions in unprotected sex with HIV-negative and unknown-status partners; and will show stricter adherence to their treatment regimens, compared to the individuals in the standard-of-care, control group.
 
Phase II
Interventional
Prevention, Randomized, Open Label, Active Control, Factorial Assignment, Efficacy Study
HIV
Behavioral: TAP: Treatment Advocacy Program
 
 

*   Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.
 
Active, not recruiting
300
June 2006
 

Inclusion Criteria:

  • HIV+ men who have sex with other men, age 18 or over, in HIV care at one of the collaborating clinics, any sexual contact within the previous six months.

Exclusion Criteria:

  • self-reported low likelihood of remaining in treatment or in the study location for 12 months, inability to comprehend the consent quiz administered during the Consent and Enrollment Visit, or unwilling to provide required locator information
Male
18 Years and older
 
Contact information is only displayed when the study is recruiting subjects
United States
 
NCT00164333
 
CDC-NCHSTP-3797, R 18/CCR520972-01
Centers for Disease Control and Prevention
 
Principal Investigator: Dogan Eroglu, PhD. Centers for Disease Control and Prevention
Centers for Disease Control and Prevention
September 2005

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP




Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services